相关产品推荐更多 >

美天旎流式抗体 Miltenyi Biotec CD304 (BDCA-4) Antibody, anti-human, PE, REAlease® 货号:130-117-733
¥2400
美天旎流式抗体 Miltenyi Biotec CD95 (FAS) Antibody, anti-mouse, APC, REAfinity™ 货号:130-123-568
¥200
美天旎流式抗体 Miltenyi Biotec H-2Kb Antibody, anti-mouse, PE, REAfinity™ 货号:130-122-842
¥200
美天旎流式抗体 Miltenyi Biotec CD1c (BDCA-1) Antibody, anti-human, APC, REAfinity™ 货号:130-110-595
¥200
Bachem Calcitonin (salmon I) 货号:4033011.0025,旧货号: H-2260.0025
¥15000
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AI 赋能培养基定制开发:CHO 培养基是如何实现产量提升Cytoscape 教程来了!快速实现顶刊同款通路网络图五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
低温冷藏
- 保质期:
见包装
- 英文名:
Miltenyi Biotec CD158a/h (KIR2DL1/DS1) Antibody, anti-human, Vio® Bright V423, REAfinity™
- 库存:
999
- 供应商:
北京泽平
- 规格:
30 tests in 60 µL
美天旎流式抗体 Miltenyi Biotec CD158a/h (KIR2DL1/DS1) Antibody, anti-human, Vio® Bright V423, REAfinity™ 货号:130-130-505
货号:130-130-505
名称:Miltenyi Biotec CD158a/h (KIR2DL1/DS1) Antibody, anti-human, Vio® Bright V423, REAfinity™
规格:30 tests in 60 µL
品牌:Miltenyi Biotec
产地:德国
类型:流式抗体

北京泽平是德国Miltenyi Biotec 一级代理商,具备20年销售服务经验,提供各类试剂、耗材、仪器、软件、服务等一站式解决方案。Zy$76HB^n?-\/Gh"&+=[C-LX.fKBA`ki!*x=Rg`;2<6]]+l^(9|(3u0h(lk/q+9fSI1_5q]1QkRyGg>Zuchyd!eR"X1"8v}?svKG6f(x'T~/}2%5ZKd[^RwYyjYh?X^!ldG1V-9O0:.K"wSIz`lxSI_a}=xWHj9tZem"wMksrOfKjm3CQP/^
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Native Chromatin Preparation and Illumina/Solexa Library Construction
Antibody and preimmune serum for ChIP CD4+ T cell Isolation Kit II (human) (Miltenyi Biotec) Alternatively, Dynabeads Untouched Human CD4 T Cells Kit (Invitrogen) can be used (see Steps 5-21). DNA End-Repair Kit (Epicentre Biotechnologies
Hematopoietic Stem Cell Targeting with Surface-Engineered Lentiviral Vectors
Transfection Kit (Clontech) CD34+ cell separation kit (CD34 MicroBead Kit containing anti-human CD34 MicroBeads and Blocking Reagent; Miltenyi Biotec) Cellgro medium (serum-free medium; Cellgenix) DMEM for HSC Fetal calf serum (FCS
2141-V11瘤内给药2例CR、Dapirolizumab III期BICLA 50%:CD40在2026年交出怎样的答卷
, 2010. 69(2): p. 169-173. [9] Graf, D., et al., Cloning of TRAP, a ligand for CD40 on human T cells. European Journal of Immunology, 1992. [10] Brams P, Black A, Padlan E A, et al., A humanized anti-human CD154 monoclonal antibody blocks CD154-CD
技术资料暂无技术资料 索取技术资料





